These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2087443)

  • 21. A pharmacological tool to assess vasopressinergic co-activation of the hypothalamus-pituitary-adrenal axis more integrally in healthy volunteers.
    Jacobs GE; van Gerven JM; de Kam Ml; Elassaiss-Schaap J; Ruigt G; van Pelt J; Peeters BW; Peeters PA; Hulskotte EG
    J Psychopharmacol; 2011 Mar; 25(3):361-9. PubMed ID: 20147570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desamino-D-arg8-vasopressin (DDAVP), unlike ethanol, has no effect on a boring visual vigilance task in humans.
    Sahgal A; Wright C; Ferrier IN
    Psychopharmacology (Berl); 1986; 90(1):58-63. PubMed ID: 3094063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
    Yang X; Disa J; Rao AK
    Thromb Res; 1990 Sep; 59(5):809-18. PubMed ID: 2237837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation between urine osmolality and urinary excretion of aquaporin-2 in healthy volunteers.
    Baumgarten R; van de Pol MH; Deen PM; van Os CH; Wetzels JF
    Nephrol Dial Transplant; 2000 Aug; 15(8):1155-61. PubMed ID: 10910438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of DDAVP on plasma renin activity in man.
    Radó JP; Boer P
    Int J Clin Pharmacol Biopharm; 1979 Jul; 17(7):307-10. PubMed ID: 489197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers.
    Fjellestad-Paulsen A; Höglund P; Lundin S; Paulsen O
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):177-82. PubMed ID: 8435898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet surface activation markers after DDAVP infusion in healthy subjects.
    Tsakiris DA; Haefeli WE; Linder L; Steiner B; Marbet GA
    Thromb Haemost; 1995 Sep; 74(3):991-2. PubMed ID: 8571336
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additive effect of dDAVP and standard heparin in increasing plasma t-PA.
    Agnelli G; Levi M; Cosmi B; ten Cate JW; Nenci GG
    Thromb Haemost; 1989 Jun; 61(3):507-10. PubMed ID: 2508260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor.
    Saito M; Tahara A; Sugimoto T
    Biochem Pharmacol; 1997 Jun; 53(11):1711-7. PubMed ID: 9264324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
    Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
    J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasopressin analog influences the performance of males on a reaction time task.
    Beckwith BE; Couk DI; Till TS
    Peptides; 1983; 4(5):707-9. PubMed ID: 6657514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma.
    Konecka G; Bykowska K; Ludwicka A; Letowska M; Wegrzynowicz Z; Sablinski J; Lopaciuk S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):565-70. PubMed ID: 1714861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.
    Kaufmann JE; Oksche A; Wollheim CB; Günther G; Rosenthal W; Vischer UM
    J Clin Invest; 2000 Jul; 106(1):107-16. PubMed ID: 10880054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desmopressin as a pharmacological tool in vasopressinergic hypothalamus-pituitary-adrenal axis modulation: neuroendocrine, cardiovascular and coagulatory effects.
    Jacobs GE; Hulskotte EG; van Gerven JM; Zuurman L; de Kam ML; Elassaiss-Schaap J; Ruigt G; van Pelt J; Peeters BW; Peeters PA; Burggraaf J
    J Psychopharmacol; 2011 Mar; 25(3):353-60. PubMed ID: 20142306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory.
    van Ruitenbeek P; Vermeeren A; Riedel W
    J Psychopharmacol; 2008 Aug; 22(6):663-72. PubMed ID: 18208925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidiuretic effect of perorally administered DDAVP in hydrated humans.
    Vilhardt H; Bie P
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):474-6. PubMed ID: 6720233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.